NZ182556A - Tricylick azacyloalkanones - Google Patents

Tricylick azacyloalkanones

Info

Publication number
NZ182556A
NZ182556A NZ182556A NZ18255676A NZ182556A NZ 182556 A NZ182556 A NZ 182556A NZ 182556 A NZ182556 A NZ 182556A NZ 18255676 A NZ18255676 A NZ 18255676A NZ 182556 A NZ182556 A NZ 182556A
Authority
NZ
New Zealand
Prior art keywords
designates
phenyl
alkyl
oxygen
image
Prior art date
Application number
NZ182556A
Other languages
English (en)
Inventor
A Fisher
S Cohen
Original Assignee
Mundipharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma Ag filed Critical Mundipharma Ag
Publication of NZ182556A publication Critical patent/NZ182556A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ182556A 1975-11-11 1976-11-08 Tricylick azacyloalkanones NZ182556A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL48453A IL48453A (en) 1975-11-11 1975-11-11 Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
NZ182556A true NZ182556A (en) 1979-10-25

Family

ID=11048546

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ182556A NZ182556A (en) 1975-11-11 1976-11-08 Tricylick azacyloalkanones

Country Status (22)

Country Link
US (1) US4083985A (enExample)
JP (2) JPS6045198B2 (enExample)
AR (1) AR213184A1 (enExample)
AT (1) AT355035B (enExample)
AU (1) AU511347B2 (enExample)
BE (1) BE848227A (enExample)
CA (1) CA1078385A (enExample)
CH (2) CH635102A5 (enExample)
DE (1) DE2650876A1 (enExample)
DK (1) DK507376A (enExample)
ES (1) ES453162A1 (enExample)
FI (1) FI60013C (enExample)
FR (1) FR2331339A1 (enExample)
GB (1) GB1571511A (enExample)
IL (1) IL48453A (enExample)
IN (1) IN145202B (enExample)
MX (1) MX4767E (enExample)
NL (1) NL7612427A (enExample)
NO (1) NO144927C (enExample)
NZ (1) NZ182556A (enExample)
SE (1) SE435929B (enExample)
ZA (1) ZA766663B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183938A (en) * 1975-11-11 1980-01-15 The Purdue Frederick Company 1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereof
US4855290A (en) 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5407938A (en) * 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
JPH0518551U (ja) * 1991-08-28 1993-03-09 亀吉 立花 ぶら下がり健康器
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
US5521193A (en) * 1992-06-24 1996-05-28 G. D. Searle & Co. Benzimidazole compounds
US5534521A (en) * 1993-06-23 1996-07-09 G. D. Searle & Co. Benzimidazole compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857837A (en) * 1968-07-02 1974-12-31 Hoffmann La Roche Processes and intermediated for quinine, quinidine, isomers and derivatives thereof

Also Published As

Publication number Publication date
FR2331339A1 (fr) 1977-06-10
JPS6045198B2 (ja) 1985-10-08
JPS5283396A (en) 1977-07-12
US4083985A (en) 1978-04-11
FR2331339B1 (enExample) 1980-04-04
AU511347B2 (en) 1980-08-14
IN145202B (enExample) 1978-09-09
JPS6043348B2 (ja) 1985-09-27
NO144927B (no) 1981-08-31
FI60013C (fi) 1981-11-10
NO763820L (enExample) 1977-05-12
AR213184A1 (es) 1978-12-29
AT355035B (de) 1980-02-11
AU1955276A (en) 1978-05-18
NL7612427A (nl) 1977-05-13
JPS60120876A (ja) 1985-06-28
CH640234A5 (de) 1983-12-30
CA1078385A (en) 1980-05-27
GB1571511A (en) 1980-07-16
SE435929B (sv) 1984-10-29
IL48453A (en) 1980-06-30
CH635102A5 (de) 1983-03-15
ES453162A1 (es) 1977-11-01
SE8003351L (sv) 1980-05-05
BE848227A (fr) 1977-03-01
ATA839476A (de) 1979-07-15
FI60013B (fi) 1981-07-31
FI763152A7 (enExample) 1977-05-12
NO144927C (no) 1981-12-09
MX4767E (es) 1982-09-08
DE2650876A1 (de) 1977-05-18
IL48453A0 (en) 1976-01-30
DK507376A (da) 1977-05-12
ZA766663B (en) 1977-10-26

Similar Documents

Publication Publication Date Title
NO152130C (no) Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser
DK623586D0 (da) Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
DK114783A (da) Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
ATE18765T1 (de) Pharmazeutische zusammenstellungen.
DK159148C (da) Analogifremgangsmaade til fremstilling af tranexamsyrederivater
ATE9793T1 (de) 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8403801D0 (sv) Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem
ES444870A1 (es) Procedimiento para preparar derivados de oxadiazolinona.
ATE153666T1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
IL48453A (en) Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them
JPS5297934A (en) N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s
FI894068A0 (fi) Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel.
SE7412163L (enExample)
ES443288A1 (es) Procedimiento para la preparacion de penicilinas.
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
DK513281A (da) Fremgangsaade til fremstilling af 3-thiovinylcephalosproner
JPS525767A (en) Preparation of novel organic compounds
JPS5214763A (en) Succinimide-type germicides for agricultural and gardening use
GB1526938A (en) Derivatives of n-phenyl-n-aroylalanine and herbicidal compositions containing them
JPS5414987A (en) Novel s-triazine compounds and its preparation
ATE1550T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE7909980L (sv) I-amino-indolin-derivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
ES8304989A1 (es) Mejoras introducidas en un procedimiento para la preparacion hidroximidatos y tiolhidroximidatos heterobiciclicos y de- rivados ester carbomatos de los mismos.